Breaking News Instant updates and real-time market news.

MRK

Merck

$86.40 /

-0.445 (-0.51%)

, VTRS

Viatris

$8.57 /

-0.145 (-1.66%)

15:25
09/29/22
09/29
15:25
09/29/22
15:25

Merck says appeals court rules in company's favor on sitagliptin patent

Merck (MRK) announced that the U.S. Court of Appeals for the Federal Circuit ruled in favor of the company in a patent challenge brought by Mylan Pharmaceuticals, now Viatris (VTRS), related to sitagliptin dihydrogen phosphate, an active ingredient in Januvia, Janumet, and Janumet XR. Viatris had challenged validity of U.S. Patent No.7,326,708 in an inter partes review before the U.S. Patent Office. On May 7, 2021, the Patent Office issued a decision in Merck's favor, finding all challenged claims valid. Viatris appealed that decision to the Court of Appeals for the Federal Circuit, which today affirmed the decision. Viatris had previously challenged validity of the patent in a case filed in the U.S. District Court for the Northern District of West Virginia. The District Court ruled in favor of Merck in a decision dated Sept. 21, 2022. "Today's ruling from the U.S. Court of Appeals provides Januvia, Janumet, and Janumet XR patent protection through May 2027, which includes six months of pediatric exclusivity. The company has settled with multiple generic companies, providing that these generic companies can bring their sitagliptin dihydrogen phosphate or sitagliptin-metformin product to the market in May 2026 or earlier under certain circumstances, and their sitagliptin-metformin extended-release product to the market in July 2026 or earlier under certain circumstances," Merck stated.

MRK

Merck

$86.40 /

-0.445 (-0.51%)

VTRS

Viatris

$8.57 /

-0.145 (-1.66%)

  • 04

    Oct

  • 13

    Oct

  • 27

    Oct

  • 29

    Jan

OTHER BREAKING NEWS FROM THE FLY

Options
DocuSign put volume heavy and directionally bearish » 15:35
12/05/22
12/05
15:35
12/05/22
15:35
DOCU

DocuSign

$42.43 /

-4.145 (-8.90%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DOCU DocuSign
$42.43 /

-4.145 (-8.90%)

DOCU DocuSign
$42.43 /

-4.145 (-8.90%)

07:34 Today UBS
DocuSign price target lowered to $52 from $65 at UBS
07:12 Today Baird
DocuSign price target lowered to $50 from $70 at Baird
11/30/22 Jefferies
DocuSign initiated with a Hold at Jefferies
10/12/22 Wedbush
Wedbush upgrades DocuSign to Neutral with $55 price target
DOCU DocuSign
$42.43 /

-4.145 (-8.90%)

DOCU DocuSign
$42.43 /

-4.145 (-8.90%)

DOCU DocuSign
$42.43 /

-4.145 (-8.90%)

DOCU DocuSign
$42.43 /

-4.145 (-8.90%)

Options
Southwestern Energy call volume above normal and directionally bullish » 15:25
12/05/22
12/05
15:25
12/05/22
15:25
SWN

Southwestern Energy

$6.12 /

-0.36 (-5.56%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWN Southwestern Energy
$6.12 /

-0.36 (-5.56%)

SWN Southwestern Energy
$6.12 /

-0.36 (-5.56%)

10/19/22 Jefferies
Southwestern Energy initiated with a Buy at Jefferies
10/03/22 Truist
Southwestern Energy upgraded to Buy at Truist on more natural gas price hikes
10/03/22 Truist
Southwestern Energy upgraded to Buy from Hold at Truist
09/21/22 Citi
Southwestern Energy price target raised to $10 from $8 at Citi
SWN Southwestern Energy
$6.12 /

-0.36 (-5.56%)

  • 13
    Dec
SWN Southwestern Energy
$6.12 /

-0.36 (-5.56%)

SWN Southwestern Energy
$6.12 /

-0.36 (-5.56%)

Technical Analysis
NASDAQ market internals summary » 15:17
12/05/22
12/05
15:17
12/05/22
15:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 15:16
12/05/22
12/05
15:16
12/05/22
15:16
$NYE

NYSE Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Conference/Events
Provention Bio management to meet virtually with Oppenheimer » 15:12
12/05/22
12/05
15:12
12/05/22
15:12
PRVB

Provention Bio

$8.91 /

-0.505 (-5.36%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRVB Provention Bio
$8.91 /

-0.505 (-5.36%)

PRVB Provention Bio
$8.91 /

-0.505 (-5.36%)

11/22/22 Guggenheim
MacroGenics upgraded to Buy at Guggenheim ahead of near-term catalysts
11/19/22 Chardan
Provention Bio price target raised to $30 from $24 at Chardan
11/18/22 Jefferies
Provention Bio price target raised to $22 from $18 at Jefferies
10/06/22 Jefferies
Provention Bio price target raised to $15 from $10 at Jefferies
PRVB Provention Bio
$8.91 /

-0.505 (-5.36%)

PRVB Provention Bio
$8.91 /

-0.505 (-5.36%)

PRVB Provention Bio
$8.91 /

-0.505 (-5.36%)

Hot Stocks
Sorrento presents Phase 2 results on PD-L1 checkpoint inhibitor IMC-001 » 15:04
12/05/22
12/05
15:04
12/05/22
15:04
SRNE

Sorrento Therapeutics

$1.17 /

-0.095 (-7.54%)

Sorrento Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRNE Sorrento Therapeutics
$1.17 /

-0.095 (-7.54%)

SRNE Sorrento Therapeutics
$1.17 /

-0.095 (-7.54%)

11/02/22 Cantor Fitzgerald
Sorrento Therapeutics initiated with an Overweight at Cantor Fitzgerald
11/02/22 Cantor Fitzgerald
Sorrento Therapeutics initiated with an Overweight at Cantor Fitzgerald
03/25/22 H.C. Wainwright
Sorrento Therapeutics price target lowered to $20 from $26 at H.C. Wainwright
12/28/21 H.C. Wainwright
H.C. Wainwright reiterates $26 target on Sorrento after Covistix news
SRNE Sorrento Therapeutics
$1.17 /

-0.095 (-7.54%)

SRNE Sorrento Therapeutics
$1.17 /

-0.095 (-7.54%)

Hot Stocks
Tango Therapeutics treatment of malignant glioma granted orphan designation » 14:56
12/05/22
12/05
14:56
12/05/22
14:56
TNGX

Tango Therapeutics

$7.83 /

-0.09 (-1.14%)

Tango Therapeutics'…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TNGX Tango Therapeutics
$7.83 /

-0.09 (-1.14%)

TNGX Tango Therapeutics
$7.83 /

-0.09 (-1.14%)

10/20/22 H.C. Wainwright
Tango Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
TNGX Tango Therapeutics
$7.83 /

-0.09 (-1.14%)

Conference/Events
PubMatic management to meet with Oppenheimer » 14:55
12/05/22
12/05
14:55
12/05/22
14:55
PUBM

PubMatic

$14.75 /

-1.13 (-7.12%)

Meeting to be held with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PUBM PubMatic
$14.75 /

-1.13 (-7.12%)

PUBM PubMatic
$14.75 /

-1.13 (-7.12%)

11/09/22 Lake Street
PubMatic price target lowered to $19 from $24 at Lake Street
11/09/22 JMP Securities
PubMatic price target lowered to $22 from $34 at JMP Securities
11/09/22 Oppenheimer
PubMatic price target lowered to $23 from $28 at Oppenheimer
08/09/22 Lake Street
PubMatic price target lowered to $24 from $26 at Lake Street
PUBM PubMatic
$14.75 /

-1.13 (-7.12%)

PUBM PubMatic
$14.75 /

-1.13 (-7.12%)

General news
Market Action: bonds and stocks remain under pressure » 14:55
12/05/22
12/05
14:55
12/05/22
14:55
$ECON

Economic Data

/

+

Market Action: bonds and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Periodicals
Tesla says Shanghai plant output cut reports 'untrue,' Reuters says » 14:45
12/05/22
12/05
14:45
12/05/22
14:45
TSLA

Tesla

$182.05 /

-12.8 (-6.57%)

Tesla China said that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$182.05 /

-12.8 (-6.57%)

TSLA Tesla
$182.05 /

-12.8 (-6.57%)

14:37 Today Piper Sandler
If Tesla cuts production in China, it won't be due to competition, says Piper
11/29/22 Bernstein
Tesla risk/reward 'more balanced' after 48% drop, says Bernstein
11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
11/23/22 Morgan Stanley
Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff
TSLA Tesla
$182.05 /

-12.8 (-6.57%)

TSLA Tesla
$182.05 /

-12.8 (-6.57%)

TSLA Tesla
$182.05 /

-12.8 (-6.57%)

TSLA Tesla
$182.05 /

-12.8 (-6.57%)

Options
Colgate Palmolive call volume above normal and directionally bullish » 14:45
12/05/22
12/05
14:45
12/05/22
14:45
CL

Colgate-Palmolive

$77.19 /

-0.955 (-1.22%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CL Colgate-Palmolive
$77.19 /

-0.955 (-1.22%)

CL Colgate-Palmolive
$77.19 /

-0.955 (-1.22%)

11/22/22 Wolfe Research
Colgate-Palmolive initiated with a Peer Perform at Wolfe Research
11/21/22 Wolfe Research
Colgate-Palmolive initiated with a Peer Perform at Wolfe Research
11/01/22 Barclays
Colgate-Palmolive price target raised to $76 from $72 at Barclays
10/17/22 Deutsche Bank
Colgate-Palmolive price target lowered to $85 from $87 at Deutsche Bank
CL Colgate-Palmolive
$77.19 /

-0.955 (-1.22%)

CL Colgate-Palmolive
$77.19 /

-0.955 (-1.22%)

CL Colgate-Palmolive
$77.19 /

-0.955 (-1.22%)

CL Colgate-Palmolive
$77.19 /

-0.955 (-1.22%)

Conference/Events
JPMorgan energy analyst to hold an analyst/industry conference call » 14:45
12/05/22
12/05
14:45
12/05/22
14:45

Analyst Anavy discuss…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
AIB Group price target raised to EUR 3.80 from EUR 3.40 at Barclays » 14:43
12/05/22
12/05
14:43
12/05/22
14:43
AIBRF

AIB Group

$3.12 /

+ (+0.00%)

Barclays analyst Aman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AIBRF AIB Group
$3.12 /

+ (+0.00%)

11/29/22 Deutsche Bank
AIB Group price target raised to EUR 4.20 from EUR 3.70 at Deutsche Bank
11/23/22 Morgan Stanley
AIB Group price target raised to EUR 3.30 from EUR 3 at Morgan Stanley
11/02/22 Berenberg
AIB Group price target raised to EUR 3.80 from EUR 3.20 at Berenberg
10/31/22 JPMorgan
AIB Group price target raised to EUR 3.80 from EUR 3.20 at JPMorgan
Periodicals
BP bets big on hydrogen as fuel of the future, Reuters reports » 14:43
12/05/22
12/05
14:43
12/05/22
14:43
BP

BP

$34.93 /

-0.435 (-1.23%)

BP CEO Bernard Looney is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BP BP
$34.93 /

-0.435 (-1.23%)

BP BP
$34.93 /

-0.435 (-1.23%)

12/02/22 JPMorgan
BP price target raised to 560 GBp from 530 GBp at JPMorgan
11/22/22 Citi
BP upgraded to Buy from Neutral at Citi
11/14/22 Wells Fargo
Archaea Energy downgraded to Equal Weight from Overweight at Wells Fargo
11/11/22 Piper Sandler
BP price target raised to $40 from $37 at Piper Sandler
BP BP
$34.93 /

-0.435 (-1.23%)

BP BP
$34.93 /

-0.435 (-1.23%)

BP BP
$34.93 /

-0.435 (-1.23%)

BP BP
$34.93 /

-0.435 (-1.23%)

Hot Stocks
J&J says 'it does not intent to make offer' for Horizon Therapeutics » 14:41
12/05/22
12/05
14:41
12/05/22
14:41
JNJ

Johnson & Johnson

$178.58 /

-0.26 (-0.15%)

, HZNP

Horizon Therapeutics

$98.90 /

-5.92 (-5.65%)

Johnson & Johnson…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$178.58 /

-0.26 (-0.15%)

HZNP Horizon Therapeutics
$98.90 /

-5.92 (-5.65%)

JNJ Johnson & Johnson
$178.58 /

-0.26 (-0.15%)

12/01/22 Jefferies
Horizon Therapeutics price target raised to $125 from $101 at Jefferies
12/01/22 Morgan Stanley
Johnson & Johnson price target raised to $178 from $170 at Morgan Stanley
11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
11/29/22 Craig-Hallum
Craig-Hallum sees potential for competing Apollo Endosurgery bids
HZNP Horizon Therapeutics
$98.90 /

-5.92 (-5.65%)

12/01/22 Jefferies
Horizon Therapeutics price target raised to $125 from $101 at Jefferies
11/30/22 Cowen
Horizon Therapeutics takeout in $120-$140 range reasonable, says Cowen
11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
11/01/22 H.C. Wainwright
Horizon Therapeutics initiated with a Neutral at H.C. Wainwright
JNJ Johnson & Johnson
$178.58 /

-0.26 (-0.15%)

HZNP Horizon Therapeutics
$98.90 /

-5.92 (-5.65%)

JNJ Johnson & Johnson
$178.58 /

-0.26 (-0.15%)

HZNP Horizon Therapeutics
$98.90 /

-5.92 (-5.65%)

JNJ Johnson & Johnson
$178.58 /

-0.26 (-0.15%)

HZNP Horizon Therapeutics
$98.90 /

-5.92 (-5.65%)

JNJ Johnson & Johnson
$178.58 /

-0.26 (-0.15%)

HZNP Horizon Therapeutics
$98.90 /

-5.92 (-5.65%)

Recommendations
Compass Group price target raised to 1,625 GBp from 1,575 GBp at RBC Capital » 14:39
12/05/22
12/05
14:39
12/05/22
14:39
CMPGY

Compass Group

$23.09 /

+0.26 (+1.14%)

RBC Capital analyst Karl…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMPGY Compass Group
$23.09 /

+0.26 (+1.14%)

09/22/22 AlphaValue/Baader
Compass Group upgraded to Add from Sell at AlphaValue/Baader
09/07/22 Morgan Stanley
Compass Group price target raised to 2,200 GBp from 2,150 GBp at Morgan Stanley
08/19/22 Jefferies
Compass Group downgraded to Hold from Buy at Jefferies
08/01/22 Berenberg
Compass Group price target raised to 2,100 GBp from 2,050 GBp at Berenberg
Recommendations
If Tesla cuts production in China, it won't be due to competition, says Piper » 14:37
12/05/22
12/05
14:37
12/05/22
14:37
TSLA

Tesla

$182.07 /

-12.78 (-6.56%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$182.07 /

-12.78 (-6.56%)

TSLA Tesla
$182.07 /

-12.78 (-6.56%)

11/29/22 Bernstein
Tesla risk/reward 'more balanced' after 48% drop, says Bernstein
11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
11/23/22 Morgan Stanley
Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff
11/23/22 Citi
Tesla upgraded to Neutral from Sell at Citi
TSLA Tesla
$182.07 /

-12.78 (-6.56%)

TSLA Tesla
$182.07 /

-12.78 (-6.56%)

TSLA Tesla
$182.07 /

-12.78 (-6.56%)

TSLA Tesla
$182.07 /

-12.78 (-6.56%)

On The Fly
Fly Insider: Vapotherm, Applovin among week's notable insider trades » 14:36
12/05/22
12/05
14:36
12/05/22
14:36
HHC

Howard Hughes

$72.73 /

-2.44 (-3.25%)

, ET

Energy Transfer LP

$12.26 /

-0.265 (-2.12%)

, ACER

Acer Therapeutics

$1.57 /

+0.085 (+5.72%)

, VAPO

Vapotherm

$1.58 /

-0.02 (-1.25%)

, ADM

Archer Daniels

$90.10 /

-1.62 (-1.77%)

, APP

AppLovin

$12.90 /

-1.39 (-9.73%)

, ADI

Analog Devices

$167.75 /

-0.81 (-0.48%)

, A

Agilent

$152.52 /

-3.07 (-1.97%)

Welcome to "Fly Insider,"…

ShowHide Related Items >><<
HHC Howard Hughes
$72.73 /

-2.44 (-3.25%)

ET Energy Transfer LP
$12.26 /

-0.265 (-2.12%)

ACER Acer Therapeutics
$1.57 /

+0.085 (+5.72%)

VAPO Vapotherm
$1.58 /

-0.02 (-1.25%)

ADM Archer Daniels
$90.10 /

-1.62 (-1.77%)

APP AppLovin
$12.90 /

-1.39 (-9.73%)

ADI Analog Devices
$167.75 /

-0.81 (-0.48%)

A Agilent
$152.52 /

-3.07 (-1.97%)

HHC Howard Hughes
$72.73 /

-2.44 (-3.25%)

10/07/22 Piper Sandler
Howard Hughes price target lowered to $81 from $100 at Piper Sandler
07/26/22 BMO Capital
Howard Hughes initiated with an Outperform at BMO Capital
06/30/22 Jefferies
Howard Hughes price target lowered to $90 from $127 at Jefferies
04/14/22 Piper Sandler
Howard Hughes price target raised to $120 from $115 at Piper Sandler
ET Energy Transfer LP
$12.26 /

-0.265 (-2.12%)

10/19/22 Morgan Stanley
Energy Transfer LP price target raised to $17 from $15 at Morgan Stanley
08/16/22 Barclays
Energy Transfer LP price target raised to $14 from $13 at Barclays
07/20/22 Barclays
Energy Transfer LP price target lowered to $13 from $14 at Barclays
04/26/22 Morgan Stanley
Energy Transfer LP price target raised to $15 from $12 at Morgan Stanley
ACER Acer Therapeutics
$1.57 /

+0.085 (+5.72%)

01/11/22 H.C. Wainwright
Acer Therapeutics assumed with a Buy at H.C. Wainwright
VAPO Vapotherm
$1.58 /

-0.02 (-1.25%)

11/03/22 Piper Sandler
Vapotherm price target lowered to $1 from $2 at Piper Sandler
10/03/22 Piper Sandler
Vapotherm's latest debt amendment 'more consequential', says Piper Sandler
08/04/22 BTIG
Vapotherm downgraded to Neutral from Buy at BTIG
08/04/22 William Blair
Vapotherm downgraded to Market Perform from Outperform at William Blair
ADM Archer Daniels
$90.10 /

-1.62 (-1.77%)

10/26/22 Baird
Archer Daniels price target raised to $98 from $94 at Baird
10/24/22 BofA
Green Plains price target lowered to $35 from $43 at BofA
10/24/22 BofA
Archer Daniels price target lowered to $100 from $104 at BofA
10/04/22 Lake Street
Benson Hill initiated with a Buy at Lake Street
APP AppLovin
$12.90 /

-1.39 (-9.73%)

11/30/22 Jefferies
AppLovin initiated with a Hold at Jefferies
11/28/22 Morgan Stanley
AppLovin downgraded to Equal Weight from Overweight at Morgan Stanley
11/22/22 Citi
AppLovin price target lowered to $34 from $60 at Citi
11/17/22 JPMorgan
AppLovin reinstated with Neutral from Overweight at JPMorgan
ADI Analog Devices
$167.75 /

-0.81 (-0.48%)

11/23/22 Deutsche Bank
Analog Devices price target raised to $170 from $155 at Deutsche Bank
11/23/22 Evercore ISI
Analog Devices price target raised to $195 from $185 at Evercore ISI
11/23/22 Truist
Analog Devices price target raised to $214 from $209 at Truist
11/23/22 Cowen
Analog Devices price target raised to $190 from $180 at Cowen
A Agilent
$152.52 /

-3.07 (-1.97%)

11/22/22 Jefferies
Agilent price target raised to $168 from $158 at Jefferies
11/22/22 Evercore ISI
Agilent price target raised to $155 from $140 at Evercore ISI
11/22/22 Cowen
Agilent price target raised to $168 from $160 at Cowen
11/22/22 Wells Fargo
Agilent price target raised to $150 from $135 at Wells Fargo
HHC Howard Hughes
$72.73 /

-2.44 (-3.25%)

ET Energy Transfer LP
$12.26 /

-0.265 (-2.12%)

ACER Acer Therapeutics
$1.57 /

+0.085 (+5.72%)

VAPO Vapotherm
$1.58 /

-0.02 (-1.25%)

ADM Archer Daniels
$90.10 /

-1.62 (-1.77%)

APP AppLovin
$12.90 /

-1.39 (-9.73%)

ADI Analog Devices
$167.75 /

-0.81 (-0.48%)

A Agilent
$152.52 /

-3.07 (-1.97%)

  • 08
    Dec
ADM Archer Daniels
$90.10 /

-1.62 (-1.77%)

APP AppLovin
$12.90 /

-1.39 (-9.73%)

HHC Howard Hughes
$72.73 /

-2.44 (-3.25%)

ADM Archer Daniels
$90.10 /

-1.62 (-1.77%)

APP AppLovin
$12.90 /

-1.39 (-9.73%)

ADI Analog Devices
$167.75 /

-0.81 (-0.48%)

A Agilent
$152.52 /

-3.07 (-1.97%)

ET Energy Transfer LP
$12.26 /

-0.265 (-2.12%)

ADM Archer Daniels
$90.10 /

-1.62 (-1.77%)

APP AppLovin
$12.90 /

-1.39 (-9.73%)

ADI Analog Devices
$167.75 /

-0.81 (-0.48%)

A Agilent
$152.52 /

-3.07 (-1.97%)

Options
Edwards Lifesciences call volume above normal and directionally bullish » 14:25
12/05/22
12/05
14:25
12/05/22
14:25
EW

Edwards Lifesciences

$73.95 /

-2.63 (-3.43%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EW Edwards Lifesciences
$73.95 /

-2.63 (-3.43%)

EW Edwards Lifesciences
$73.95 /

-2.63 (-3.43%)

12/01/22 Wolfe Research
Wolfe Research cuts Edwards Lifesciences to Peer Perform on macro, TAVR maturity
12/01/22 Wolfe Research
Edwards Lifesciences downgraded to Peer Perform from Outperform at Wolfe Research
11/28/22 RBC Capital
Edwards Lifesciences price target lowered to $105 from $118 at RBC Capital
11/16/22 Evercore ISI
Evercore ISI removes seven Healthcare Services and Tech stocks from 'TAP' list
EW Edwards Lifesciences
$73.95 /

-2.63 (-3.43%)

EW Edwards Lifesciences
$73.95 /

-2.63 (-3.43%)

EW Edwards Lifesciences
$73.95 /

-2.63 (-3.43%)

Recommendations
Canadian Western Bank price target lowered to C$30 from C$33 at Desjardins » 14:19
12/05/22
12/05
14:19
12/05/22
14:19
CBWBF

Canadian Western Bank

$17.99 /

-1.14 (-5.96%)

Desjardins analyst Doug…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CBWBF Canadian Western Bank
$17.99 /

-1.14 (-5.96%)

11:33 Today National Bank
Canadian Western Bank price target lowered to C$31 from C$34 at National Bank
11:29 Today Raymond James
Canadian Western Bank price target lowered to C$34 from C$37 at Raymond James
11:28 Today Credit Suisse
Canadian Western Bank price target lowered to C$26 from C$27 at Credit Suisse
11:27 Today RBC Capital
Canadian Western Bank price target raised to C$36 from C$35 at RBC Capital
Conference/Events
First Foundation management to meet virtually with Stephens » 14:19
12/05/22
12/05
14:19
12/05/22
14:19
FFWM

First Foundation

$13.91 /

-0.4 (-2.80%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FFWM First Foundation
$13.91 /

-0.4 (-2.80%)

FFWM First Foundation
$13.91 /

-0.4 (-2.80%)

10/26/22 DA Davidson
First Foundation downgraded to Neutral from Buy at DA Davidson
07/27/22 B. Riley
First Foundation price target raised to $23 from $21 at B. Riley
07/11/22 B. Riley
First Foundation downgraded to Neutral from Buy at B. Riley
04/12/22 B. Riley
First Foundation price target lowered to $31 from $34 at B. Riley
FFWM First Foundation
$13.91 /

-0.4 (-2.80%)

FFWM First Foundation
$13.91 /

-0.4 (-2.80%)

Recommendations
flatexDEGIRO price target lowered to EUR 9 from EUR 11 at Deutsche Bank » 14:17
12/05/22
12/05
14:17
12/05/22
14:17
FNNTF

flatexDEGIRO

$9.83 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FNNTF flatexDEGIRO
$9.83 /

+ (+0.00%)

05:32 Today Exane BNP Paribas
flatexDEGIRO downgraded to Neutral from Outperform at Exane BNP Paribas
05:31 Today Oddo BHF
flatexDEGIRO downgraded to Neutral from Outperform at Oddo BHF
11/23/22 Morgan Stanley
flatexDEGIRO price target raised to EUR 10.10 from EUR 9.30 at Morgan Stanley
10/27/22 Berenberg
flatexDEGIRO price target lowered to EUR 18.50 from EUR 25 at Berenberg
Technical Analysis
NASDAQ market internals summary » 14:17
12/05/22
12/05
14:17
12/05/22
14:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Conference/Events
Matson management to meet virtually with Stephens » 14:16
12/05/22
12/05
14:16
12/05/22
14:16
MATX

Matson

$61.12 /

-3.37 (-5.23%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MATX Matson
$61.12 /

-3.37 (-5.23%)

MATX Matson
$61.12 /

-3.37 (-5.23%)

11/17/22 Wolfe Research
Wolfe reshuffles ratings in freight with five downgrades and one upgrade
11/17/22 Wolfe Research
Matson upgraded to Peer Perform from Underperform at Wolfe Research
10/20/22 Stifel
Matson price target lowered to $81 from $93 at Stifel
08/16/22 Wolfe Research
Wolfe starts Matson at Underperform, sees 'peak EPS' in 2022
MATX Matson
$61.12 /

-3.37 (-5.23%)

MATX Matson
$61.12 /

-3.37 (-5.23%)

Recommendations
Vantage Towers price target lowered to EUR 32 from EUR 34 at Deutsche Bank » 14:16
12/05/22
12/05
14:16
12/05/22
14:16
VTWRF

Vantage Towers

$33.80 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VTWRF Vantage Towers
$33.80 /

+ (+0.00%)

12/01/22 JPMorgan
Vantage Towers upgraded to Neutral from Underweight at JPMorgan
11/21/22 Jefferies
Vantage Towers downgraded to Hold from Buy at Jefferies
10/05/22 JPMorgan
Vantage Towers price target lowered to EUR 26.50 from EUR 27 at JPMorgan
09/06/22 Citi
Vantage Towers upgraded to Buy from Neutral at Citi

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.